Dermatology Clinical Trials Equipment Supply: 4 Key Differentiators

Over the years, we have seen a remarkable advancement in Dermatology Clinical Trials, the results of which play a pivotal role in offering new treatments and insights into various dermatological conditions.

Let’s delve into some of the success stories in Dermatology Clinical Trials and explore why equipment supply is crucial for their ongoing progress worldwide.

Success Stories in Dermatology Clinical Trials

Biologics for Psoriasis
One of the significant breakthroughs in dermatology has been the development of biologic therapies for psoriasis. Psoriasis, a chronic inflammatory skin condition, has historically been challenging to treat. Clinical trials have introduced biologics, such as TNF inhibitors and IL-17 inhibitors, which target specific pathways in the immune system. These treatments have shown remarkable efficacy in reducing the severity of psoriasis and improving the quality of life for patients.*

Targeted Therapy for Melanoma
Melanoma, a severe form of skin cancer, has seen significant advancements due to clinical trials focusing on targeted therapies. Drugs like BRAF inhibitors and MEK inhibitors have been developed to target specific mutations in melanoma cells. These therapies have increased survival rates and provided new hope for patients with advanced melanoma.^†

JAK Inhibitors for Atopic Dermatitis
Atopic dermatitis (eczema) is another area where clinical trials have made substantial contributions. JAK inhibitors, which block the Janus kinase pathway involved in inflammation, have emerged as effective treatments for moderate to severe atopic dermatitis. Clinical trials have demonstrated their ability to reduce itching and skin inflammation, offering relief to millions of sufferers.^‡

Supporting dermatology research with reliable equipment supply

As with all clinical trials, dermatology studies are not only focused on discovering new treatments but also on ensuring accuracy and efficiency. Here’s four reasons why reliable equipment supply is vital:

1. Precision and accuracy

Reliability with equipment used provides precise and accurate measurements during clinical trials. This is why Woodley Trial Solutions will only supply equipment with proven reliability for clinical studies; but also provide equipment and device calibration to ensure safety and accuracy.

Moreover, Woodley Trial Solutions continually stay grounded in science, and keep abreast of latest technology connected devices, thus maintaining strong accuracy, and provided quicker access to secure patient data.

2. Consistency Across sites

Dermatology clinical trials often take place across multiple sites worldwide. With outstanding global logistics expertise, Woodley Trial Solutions ensure that the equipment supplied is regulated for use in your study locations. This ensures that data from calibrated and vetted equipment remains consistent across all study sites, which is a crucial factor for trial results integrity.

3. Minimizing downtime

Delays in equipment supply can significantly hinder the progress of clinical trials. With a reliable and communicative global logistics team, Woodley Trial Solutions stay focused on supplying your equipment ahead of your SIV, thereby ensuring any downtime is completely minimised. Specialised delivery is also available, which includes taking equipment directly to the required location on-site, and even unboxing. Plus, when technical support is required with equipment setup, our Project Management team can quickly help.

4. Regulatory compliance

As we are all aware, Clinical Trials must adhere to stringent regulatory standards. With 35 years of equipment supply expertise, Woodley Trial Solutions have vast knowledge and understanding of product regulatory requirements, and ensure that the equipment and devices we supply are regulated for use in the countries where your study is located. 

Improving patient outcomes

Dermatology clinical trials have been instrumental in bringing new, effective treatments to market, significantly improving patient outcomes for various skin conditions. There are a lot of cogs churning away in the well-oiled machine of a clinical trial, one of which is sourcing reliable equipment.

As dermatology research continues to evolve, the importance of robust equipment supply chains continues to play a strong supporting role. By prioritizing both innovative research and reliable equipment supply, we can look forward to a future where skin disorders are not only better understood but also more effectively treated.

For reliable equipment supply please get in touch with your study requirements, and we will be delighted to support you.

_Sources:
* Springer Link: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoH0) 
† National Library of Medicine: Current state of melanoma diagnosis and treatment
‡ National Library of Medicine: A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis